Through Fast Forward, we are making high-impact early-stage investments to accelerate commercial Research and Development for new therapies and diagnostics for MS.
As a driving force of MS research to find pathways to a cure, the National MS Society takes a unique, comprehensive approach to funding research efforts. Since 2008 the National MS Society, through Fast Forward, has been driving the development of new therapies and diagnostics for people living with MS. Fast Forward bridges the preclinical commercial funding gap, targets funds to de-risk therapeutic development and catalyzes further commercial investment.
The next funding opportunity will be available October 2018.
Learn more about commercial research funding through Fast Forward
View a summary of the Fast Forward commercial funding effort (.pdf)